Recursion Pharmaceuticals, Inc. RXRX | $84.26M | 3.1 | 8.45M | 0% | +$0 | 16.01 | |
Neumora Therapeutics, Inc. Common Stock NMRA | $61.33M | 2.8 | 4.46M | 0% | +$0 | 11.65 | |
Endeavor Group Holdings, Inc. EDR | $219.64M | 1.83 | 8.54M | 0% | +$0 | 41.73 | |
Exscientia plc EXAI | $8.82M | 1.78 | 1.54M | 0% | +$0 | 1.68 | |
Lyell Immunopharma, Inc. LYEL | $3.88M | 0.68 | 1.74M | 0% | +$0 | 0.74 |